59175 Templemars 11,625 SF Office Building $1,112,510 ($95.70/SF)

ENTERPRISE Real Estate is offering an exclusive opportunity to acquire a standalone building of approximately 1,080 m², ideally located in the Templemars business park, with immediate access to the A1 highway, the Lesquin CRT, and the main economic hubs of the Lille European Metropolis.
Spread across two levels, this property is particularly suited for businesses looking to consolidate their administrative and operational functions on a single site.
The building features approximately 880 m² of office space and an activity/storage area of about 200 m², making it suitable for light production, order preparation, after-sales service, storage, or logistics activities.
This location is ideal for a company seeking a headquarters, a regional office, or mixed-use premises combining office and operational space.
Key features of the property:
- Building of approximately 1,080 m².
- Around 880 m² of office space spread across two levels.
- Approximately 200 m² of activity/storage space.
- Numerous layout possibilities tailored to your business needs.
- Ample private parking.
- Immediate access to the A1 highway and major routes within the Lille Metropolis.
- Highly sought-after area near Lille, Lesquin, and Seclin.
- Suitable for tertiary, technical, trading, or service activities requiring operational space.
Thanks to its strategic location and mixed-use configuration, this property represents a rare opportunity in the Templemars area for a company looking to own its premises.
Contact ENTERPRISE Real Estate now to receive the full dossier or schedule a visit to this exclusive opportunity.
Features:
- Building of approximately 1,080 m².
- Around 780 m² of office space spread across two levels.
- Approximately 300 m² of activity/storage space.
- Numerous layout possibilities tailored to your business needs.
- Ample private parking.
- Immediate access to the A1 highway and major routes within the Lille Metropolis.
- Highly sought-after area near Lille, Lesquin, and Seclin.